Which therapy to use for the first, second or third line of treatment for metastatic breast cancer is again under investigation because new therapies have become available for treating MBC.
Below are links that lead to discussions about lines of therapy for HER2 positive, hormone positive and triple negative metastatic breast cancer.
- 2020 Brings 3 Drugs: How the Breast Cancer Treatment Landscape Has Evolved This article by American Journal of Managed Care discusses new therapies for people with metastatic triple negative and HER2 positive disease, and for people with HER2 positive brain mets.
- Emerging Alternatives in the Third-Line Setting for Metastatic HER2-Positive Breast Cancer by ASCO Post.
- Find Clinical Trials for HER2 Positive, Hormone Positive, and Triple Negative Breast Cancer from Metastatic Trial Search.
Last Modified on February 25, 2021
Tags:HER2Hormone Receptor PositiveTreatment GuidelinesTNBCResearch News